"Lavoriamo ogni giorno insieme per vincere il cancro: il CRO è un Istituto di Ricovero e Cura a Carattere Scientifico specializzato nella cura e nella ricerca sui tumori in tutte le loro fasi: prevenzione, diagnosi, trattamento e riabilitazione. L’offerta clinica del Centro di Riferimento Oncologico comprende trattamenti di oncologia medica innovativi, chirurgia generale, senologica e ginecologica, e un’avanzata radioterapia sia curativa che palliativa. Una specifica Area Giovani è dedicata agli adolescenti con tumori. La ricerca, per lo più clinica e traslazionale, copre soprattutto la genetica e la biologia dei tumori, l’epidemiologia, le neoplasie emolinfopoietiche, i tumori solidi, i tumori associati ad agenti infettivi."

During the past decade, Centro di Riferimento Oncologico - Aviano conducted 99 clinical trials. In the 10-year time frame, 99 clinical trials started and 46 clinical trials were completed, i.e. on average, 46.5% percent of trials that started reached the finish line to date. In the past 5 years, 43 clinical trials started and 27 clinical trials were completed. i.e. 62.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro di Riferimento Oncologico - Aviano" #1 sponsor was "Hoffmann-La Roche" with 26 trials, followed by "Fondazione Italiana Linfomi ONLUS" with 18 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 14 trials sponsored, "ETOP IBCSG Partners Foundation" with 10 trials sponsored and "Centro di Riferimento Oncologico - Aviano" with 10 trials sponsored. Other sponsors include 107 different institutions and companies that sponsored additional 77 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro di Riferimento Oncologico - Aviano" #1 collaborator was "Breast International Group" with 7 trials as a collaborator, "Mario Negri Institute for Pharmacological Research" with 4 trials as a collaborator, "PharmaMar" with 4 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator and "Bristol-Myers Squibb" with 3 trials as a collaborator. Other collaborators include 110 different institutions and companies that were collaborators in the rest 103 trials.

According to Clinical.Site data, the most researched conditions in "Centro di Riferimento Oncologico - Aviano" are "Breast Cancer" (28 trials), "Lymphoma" (9 trials), "Ovarian Cancer" (8 trials), "Carcinoma, Non-Small-Cell Lung" (6 trials) and "Non-Small Cell Lung Cancer" (5 trials). Many other conditions were trialed in "Centro di Riferimento Oncologico - Aviano" in a lesser frequency.

Most popular intervention types in "Centro di Riferimento Oncologico - Aviano" are "Drug" (158 trials), "Procedure" (16 trials), "Radiation" (15 trials), "Biological" (14 trials) and "Other" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Docetaxel" (14 trials), "Paclitaxel" (13 trials), "Atezolizumab" (10 trials) and "Carboplatin" (10 trials). Other intervention names were less common.

The vast majority of trials in "Centro di Riferimento Oncologico - Aviano" are 148 trials for "All" genders, 37 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Centro di Riferimento Oncologico - Aviano". 1 are not yet recruiting, 31 are recruiting, 47 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 72 completed trials in Centro di Riferimento Oncologico - Aviano, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Centro di Riferimento Oncologico - Aviano, 9 "Phase 1" clinical trials were conducted, 65 "Phase 2" clinical trials and 91 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 12 trials that are defined as “Not Applicable".

Centro di Riferimento Oncologico - Aviano has several departments that took part in Clinical trials: "Azienda Ospedaliero-Universitaria Dipartimento Interaziendale Di Oncologia" - 16 trials, "Struttura Complessa II Medicina - Ematologia - Centro di Riferimento Ematologico - Ospedale Maggiore" - 14 trials, "Centro di Riferimento Oncologico, Divisione di Oncolgia Medica C" - 8 trials, "Ospedale Di Pordenone - S.O.C. Cardiologia" - 5 trials, "Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia" - 4 trials, "ASU FC S. M. DELLA MISERICORDIA; Oncologia" - 3 trials, "Ospedale Civile San Polo, S.O.C. Cardiologia" - 3 trials, "Divisione di Oncologia e dei Tumori immuno-correlati - IRCCS Centro di Riferimento Oncologico di Aviano" - 2 trials, "Ospedale di Cattinara, unità operativa di pneumologia" - 2 trials, "Ospedale Cattinara; Amb Studio Sclerosi Multipla, Clinica Neurlogica" - 2 trials, "Policlinico Univ. Uni Degli Sudi Di Udine; Clinica Di Reumatologia" - 2 trials, "Asui Trieste - S.C. Centro Cardiovascolare" - 2 trials, "Irccs Centro Di Riferimento Oncologico Di Aviano - Sosd Oncoematologia Trapianti Emopoietici E Terapie Cellulari" - 2 trials